Journal article · 2025 · Open access

SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques

Omotayo Farinre, Tzoalli Anaya, Alexis C. King, Kedan Endrias, Anne H. Hébert, Alison L. Hill, Sherrie M. Jean, Jennifer Wood, Stephanie Ehnert, Shan Liang, Gregory M. Laird, Rosemarie D. Mason and 4 more

PLoS Pathogens, 21(1), e1012863 · Published 10 January 2025 · DOI 10.1371/journal.ppat.1012863

Open PDFView at the publisherCite this paper

In brief

“SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques” is a 2025 journal article by Omotayo Farinre and 15 co-authors, published in PLoS Pathogens. OpenAlex counts 5 citations as of 18 November 2026. It is open access under a public domain licence: the full text is free to read at PLoS Pathogens.

Citations
5
Most cited in
2026 (4)
Field-weighted impact
1.47
References
47
Authors
16

Abstract

The latent viral reservoir remains the major barrier to HIV cure, placing the burden of strict adherence to antiretroviral therapy (ART) on people living with HIV to prevent recrudescence of viremia. For infants with perinatally acquired HIV, adherence is anticipated to be a lifelong need. In this study, we tested the hypothesis that administration of ART and viral Envelope-specific rhesus-derived IgG1 monoclonal antibodies (RhmAbs) with or without the IL-15 superagonist N-803 early in infection would limit viral reservoir establishment in SIV-infected infant rhesus macaques. Following initiation of ART at 1-2 weeks after oral SIVmac251 infection, we observed biphasic decay of viremia, with first phase decay significantly faster in the ART + SIV RhmAbs-treated group compared to controls that received only ART. In contrast, the addition of N-803 to ART + SIV RhmAbs significantly slowed both the first and second phase viral decay compared to the ART only group. Treatment with a single dose of N-803 resulted in increased frequency of Ki67 expressing NK, CD8+, and CD4+ T cells. Levels of intact SIV proviruses in CD4+ T cells from blood, lymph nodes, and rectum at week 48 of ART did not differ across groups. Similarly, the time to viral rebound following ART interruption was not impacted by the experimental treatments. These results support the concept that the rebound-competent viral reservoir is formed within days after infection and that targeting only productively infected cells for clearance near the time of ART initiation, even during acute infection, may be insufficient to limit reservoir establishment.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Farinre, O., Anaya, T., King, A. C., Endrias, K., Hébert, A. H., Hill, A. L., Jean, S. M., Wood, J., Ehnert, S., Liang, S., Laird, G. M., Mason, R. D., Roederer, M., Safrit, J. T., Mavigner, M., & Chahroudi, A. (2025). SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques. PLoS Pathogens, 21(1), e1012863. https://doi.org/10.1371/journal.ppat.1012863

MLA 9

Farinre, Omotayo, et al. “SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques.” PLoS Pathogens, vol. 21, no. 1, 2025, p. e1012863. https://doi.org/10.1371/journal.ppat.1012863.

Chicago

Farinre, Omotayo, Tzoalli Anaya, Alexis C. King, Kedan Endrias, Anne H. Hébert, Alison L. Hill, Sherrie M. Jean, et al. 2025. “SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques.” PLoS Pathogens 21 (1): e1012863. https://doi.org/10.1371/journal.ppat.1012863.

Harvard

Farinre, O. et al. (2025) ‘SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques’, PLoS Pathogens, 21(1), p. e1012863. doi:10.1371/journal.ppat.1012863.

IEEE

O. Farinre et al., “SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques,” PLoS Pathogens, vol. 21, no. 1, p. e1012863, 2025, doi: 10.1371/journal.ppat.1012863.

BibTeX

@article{farinre2025rhmabs,
  title     = {{SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques}},
  author    = {Farinre, Omotayo and Anaya, Tzoalli and King, Alexis C. and Endrias, Kedan and Hébert, Anne H. and Hill, Alison L. and Jean, Sherrie M. and Wood, Jennifer and Ehnert, Stephanie and Liang, Shan and Laird, Gregory M. and Mason, Rosemarie D. and Roederer, Mario and Safrit, Jeffrey T. and Mavigner, Maud and Chahroudi, Ann},
  journal   = {PLoS Pathogens},
  year      = {2025},
  volume    = {21},
  number    = {1},
  pages     = {e1012863},
  doi       = {10.1371/journal.ppat.1012863},
  url       = {https://doi.org/10.1371/journal.ppat.1012863}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • HIV cure
  • latent viral reservoir
  • simian immunodeficiency virus
  • rhesus monkeys
  • N-803
  • IL-15 superagonist
  • antiretroviral therapy initiation
  • viral rebound

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Farinre, O., Anaya, T., King, A. C., Endrias, K., Hébert, A. H., Hill, A. L., Jean, S. M., Wood, J., Ehnert, S., Liang, S., Laird, G. M., Mason, R. D., Roederer, M., Safrit, J. T., Mavigner, M., & Chahroudi, A. (2025). SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques. PLoS Pathogens, 21(1), e1012863. https://doi.org/10.1371/journal.ppat.1012863

How many times has this paper been cited?

5 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PLoS Pathogens: sign in and open the PDF from this page.

Who wrote this paper?

Omotayo Farinre, Tzoalli Anaya, Alexis C. King, Kedan Endrias, Anne H. Hébert, Alison L. Hill, Sherrie M. Jean, Jennifer Wood, Stephanie Ehnert, Shan Liang, Gregory M. Laird, Rosemarie D. Mason and 4 more.

What is the DOI of this paper?

10.1371/journal.ppat.1012863, permanently at https://doi.org/10.1371/journal.ppat.1012863. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.